文献速递心脏核医学肿瘤 PET/CT

冠状动脉CT血管造影后行18F-氟化钠正电子发射断层显像预测长期冠状动脉事件:一项5年随访研究

18F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study.
PubMed 文献 · J Nucl Cardiol · 2023-05-01

本研究纳入40例CCTA检出冠状动脉粥样硬化病变的患者,行18F-NaF PET/CT检查,随访5年主要冠状动脉事件(MACE)。11例患者发生MACE,MACE组患者M-TBRmax高于无MACE组(1.40±0.19 vs 1.18±0.18,P=0.0011),预测MACE的最佳M-TBRmax截断值为1.29。多因素Cox分析显示M-TBRmax≥1.29是5年MACE的独立预测因子(HR 5.4,95%CI 1.1-25.4,P=0.034)。

要点

  • MACE组患者M-TBRmax高于无MACE组(1.40±0.19 vs 1.18±0.18,P=0.0011)。
  • 预测MACE的最佳M-TBRmax截断值为1.29。
  • M-TBRmax≥1.29是5年MACE的独立预测因子(HR 5.4,95%CI 1.1-25.4,P=0.034)。

核心结论

  • CCTA后行18F-NaF PET/CT为预测5年MACE提供了有用的策略。

研究设计与样本

  • 研究纳入40例CCTA检出冠状动脉粥样硬化病变的患者,行18F-NaF PET/CT检查。
  • 共分析142处冠状动脉病变,每处病变评估管腔狭窄和高危斑块(CT值<30 Hounsfield单位且重构指数>1.1)。
  • 以每处病变最大组织本底比(TBRmax)量化局灶性18F-NaF摄取,并确定每例患者的最大TBRmax(M-TBRmax)。
  • 随访5年MACE(心源性死亡、急性冠脉综合征和/或18F-NaF PET/CT后6个月以上冠状动脉血运重建)。

主要发现

  • 11例患者发生MACE。
  • MACE组患者M-TBRmax高于无MACE组(1.40±0.19 vs 1.18±0.18,P=0.0011)。
  • 预测MACE的最佳M-TBRmax截断值为1.29。
  • M-TBRmax≥1.29患者MACE风险高于M-TBRmax较低者(P=0.012,log-rank检验),而梗阻性狭窄患者和高危斑块患者未见此差异。
  • 多因素Cox比例分析校正年龄、性别、冠状动脉危险因素和CCTA表现后,M-TBRmax≥1.29仍是5年MACE的独立预测因子(HR 5.4,95%CI 1.1-25.4,P=0.034)。

关键数值与推荐

  • 高危斑块定义为CT值<30 Hounsfield单位且重构指数>1.1。
  • 预测MACE的最佳M-TBRmax截断值为1.29。
  • M-TBRmax≥1.29预测5年MACE的HR为5.4(95%CI 1.1-25.4,P=0.034)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The predictive value of 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) in combination with coronary computed tomography (CT) angiography (CCTA) for future coronary events has attracted interest. We evaluated the potential of 18F-NaF PET/CT following CCTA to predict major coronary events (MACE) during a 5-year follow-up period. METHODS: Forty patients with coronary atherosclerotic lesions detected on CCTA underwent 18F-NaF PET/CT examination. Each lesion was evaluated for luminal stenosis and high-risk plaque (HRP) with < 30 Hounsfield units and a > 1.1 remodeling index on CCTA. Focal 18F-NaF uptake in each lesion was quantified using the maximum tissue-to-background ratio (TBRmax), and the maximum TBRmax per patient (M-TBRmax) was determined. We followed MACE (cardiac death, acute coronary syndrome, and/or coronary revascularization > 6 months after 18F-NaF PET/CT) for 5 years. RESULTS: In total, 142 coronary lesions were analyzed. Eleven patients experienced any MACE. Patients with MACE showed a higher M-TBRmax than those without (1.40 ± .19 vs. 1.18 ± .18, P = .0011), and the optimal M-TBRmax cutoff to predict MACE was 1.29. Patients with M-TBRmax of ≥ 1.29 had a higher risk of MACE than those with lower values (P = .012, log-rank test), whereas patients with obstructive stenosis and those with HRP did not. Multivariate Cox proportional analysis adjusted for age, sex, coronary risk factors, and CCTA findings showed that M-TBRmax of ≥ 1.29 remained an independent predictor of 5-year MACE (hazard ratio, 5.4; 95% confidence interval, 1.1-25.4; P = .034). CONCLUSION: 18F-NaF PET/CT following CCTA provides useful strategies to predict 5-year MACE.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Kitagawa T, Sasaki K, Fujii Y, et al. 18F-sodium fluoride positron emission tomography following coronary computed tomography angiography in predicting long-term coronary events: a 5-year follow-up study. J Nucl Cardiol. 2023. PMID: 37127726. doi:10.1007/s12350-023-03277-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。